TY - JOUR
T1 - Identifying immune signatures of sepsis to increase diagnostic accuracy in very preterm babies
AU - Das, A.
AU - Ariyakumar, G.
AU - Gupta, N.
AU - Kamdar, S.
AU - Barugahare, A.
AU - Deveson-Lucas, D.
AU - Gee, S.
AU - Costeloe, K.
AU - Davey, M. S.
AU - Fleming, P.
AU - Gibbons, D. L.
N1 - Publisher Copyright:
© 2024, The Author(s).
PY - 2024/1/9
Y1 - 2024/1/9
N2 - Bacterial infections are a major cause of mortality in preterm babies, yet our understanding of early-life disease-associated immune dysregulation remains limited. Here, we combine multi-parameter flow cytometry, single-cell RNA sequencing and plasma analysis to longitudinally profile blood from very preterm babies (<32 weeks gestation) across episodes of invasive bacterial infection (sepsis). We identify a dynamically changing blood immune signature of sepsis, including lymphopenia, reduced dendritic cell frequencies and myeloid cell HLA-DR expression, which characterizes sepsis even when the common clinical marker of inflammation, C-reactive protein, is not elevated. Furthermore, single-cell RNA sequencing identifies upregulation of amphiregulin in leukocyte populations during sepsis, which we validate as a plasma analyte that correlates with clinical signs of disease, even when C-reactive protein is normal. This study provides insights into immune pathways associated with early-life sepsis and identifies immune analytes as potential diagnostic adjuncts to standard tests to guide targeted antibiotic prescribing.
AB - Bacterial infections are a major cause of mortality in preterm babies, yet our understanding of early-life disease-associated immune dysregulation remains limited. Here, we combine multi-parameter flow cytometry, single-cell RNA sequencing and plasma analysis to longitudinally profile blood from very preterm babies (<32 weeks gestation) across episodes of invasive bacterial infection (sepsis). We identify a dynamically changing blood immune signature of sepsis, including lymphopenia, reduced dendritic cell frequencies and myeloid cell HLA-DR expression, which characterizes sepsis even when the common clinical marker of inflammation, C-reactive protein, is not elevated. Furthermore, single-cell RNA sequencing identifies upregulation of amphiregulin in leukocyte populations during sepsis, which we validate as a plasma analyte that correlates with clinical signs of disease, even when C-reactive protein is normal. This study provides insights into immune pathways associated with early-life sepsis and identifies immune analytes as potential diagnostic adjuncts to standard tests to guide targeted antibiotic prescribing.
UR - http://www.scopus.com/inward/record.url?scp=85181699942&partnerID=8YFLogxK
U2 - 10.1038/s41467-023-44387-5
DO - 10.1038/s41467-023-44387-5
M3 - Article
C2 - 38195661
AN - SCOPUS:85181699942
SN - 2041-1723
VL - 15
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 388
ER -